Feedback
We would very much appreciate any thoughts you may have about OpenCME and how it could be made more useful for physicians like you.
Professor of Medicine and Public Health
Weill Medical College of Cornell University
Attending Rheumatologist
Hospital for Special Surgery
New York, New York
| Credit Types: | CME |
| Release Date: | 2011-Jun-08 |
| Expiration Date: | 2012-Jun-07 |
| Estimated Time for Completion: | 45 minutes |
| Registration Required: | No |
| Cost: | Free |
&

This activity has been designed for rheumatologists and internists who provide care and support to patients with moderately to severely active rheumatoid arthritis. Other healthcare professionals involved in the care of these patients may also participate.
The primary goals of therapy in rheumatoid arthritis are improvement in the signs and symptoms of RA, improvement in patient-reported outcomes, and inhibition of structural progression. Recent research indicates that a treat-to-target (T2T) approach, widely accepted in other areas of medicine, is also the best way to proactively aim for these treatment goals in RA. In 2010, an international task force devised and published ten recommendations on treating RA to target (Smolen JS, Aletaha D, Bijlsma JWJ, et al. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010:69:631-637).
This CME-certified presentation hosted by Allan Gibofsky, MD, provides an overview of recent developments in the management of patients with moderate-to-severe RA including a comprehensive review of the recently published T2T recommendations.
As a result of participating in the activity, participants will be better able to
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Academy of CME and Alliance Medical Communications. The American Academy of CME is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of CME designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Support for this activity has been made possible through an educational grant from 
Dr. Allan Gibofsky disclosed that this presentation will not review off-label or investigational use of products.
According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relevant relationships with any commercial interests related to this activity. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation. All educational materials are reviewed for fair balance, scientific objectivity and levels of evidence. Disclosures are as follows:
Allan Gibofsky, MD, JD, FACP, FCLM
| Nature of Relationship | Commercial Entity |
| Advisory Board – for marketing purposes | AstraZeneca, NicOx S.A., Savient Pharmaceuticals |
| Advisory Board – for scientific purposes | Abbott Laboratories, Amgen, AstraZeneca, Hoffmann-La Roche, Human Genome Sciences, NicOx S.A., Savient Pharmaceuticals, UCB Pharma |
| Shareholder | Abbott Laboratories, Amgen, Bristol-Myers Squibb, Johnson & Johnson, Pfizer |
| Promotional Speakers' Bureau | Abbott Laboratories, Amgen, Bristol-Myers Squibb (no longer active), Pfizer, Hoffmann-La Roche, UCB Pharma |
Independent Clinical Peer Reviewer
Rodolfo V. Curiel, MD, Assistant Professor of Medicine, Rheumatology Fellowship, Program Director, The George Washington University, Washington, DC: No relevant financial relationships with any commercial interests.
Medical Writer
Melinda Tanzola, PhD: No relevant financial relationships with any commercial interests.
Planning Committee
John JD Juchniewicz, MCIS, American Academy of CME and Deborah Dean and Michelle Yechout, Alliance Medical Communications: No relevant financial relationships with any commercial interests.
To access this activity hardware and software requirements are noted below.
Windows Requirements:
Macintosh Requirements:
For more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm
© 2011. These CME activities are held as copyrighted © by the American Academy of CME and Alliance Medical Communications. Through this notice, the Academy and Alliance Medical Communications grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

"OpenCME has initially been made available in a "beta" edition with minimal content, functionality and online presence. Our editorial team is working hard to add many other specialty areas to the list above."
In a T2T approach, how often should therapy for RA be adjusted?
Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.
Please use the form below if you would like to offer your website visitors high quality CME content by adding the OpenCME Widget to one or more of your pages.